Studies from literature have suggested that mis-regulation of canonical WNT signaling can be involved in Alzheimer’s disease (AD) [78, 79] due to the fact that AD patients that carries a mutation in presenilin-1 have very low levels of β-Catenin [80]. This evidence concerns the gene PSEN1 and early-onset autosomal dominant Alzheimer disease.